OABI OmniAb Inc: Net earnings per share for the last four quarters

This chart of OmniAb, Inc. (OABI) asset value demonstrates EPS dynamics, which currently stand at 43.10. This metric is supported by AI-driven antibody discovery services that mitigate risks through numerous partnerships. High royalties in B2B deals confirm pricing power, although profit depends on the pace of client development. The business foundation is a proprietary transgenic animal system that generates revenue from future drug sales.
OABI (omniab.com): analytical breakdowns and indicator data

Investors must evaluate long-term earnings sustainability to avoid asset overvaluation risks. This metric compares net income per share for the current year with the same prior period based on 10-K and 10-Q data. By analyzing the EPS YoY TTM shift, one can identify the gap between financial performance and market price. For OmniAb, Inc. (OABI), growth in this value confirms the scalability of their robotic AI laboratories.